Today: March 23, 2017, 1:23 pm

Richard Kasteler Added to Medical Cannabis Payment Solutions Advisory Board 2014-04-16 15:02:19
CEO of Insure-Rite joins elite team of technology and strategic business leaders to help expand Medical Cannabis Payment Solutions’ footprint

Las Vegas, Nevada (FSCwire) - Business executive G. Richard Kasteler has accepted a position on the Advisory Board of Medical Cannabis Payment Solutions (OTC Bulletin Board, REFG), a leader in technological solutions for the medical cannabis industry. The Advisory Board provides guidance and strategic decision-making for the rollout of MCPS’ recently announced S2S, the industry’s most robust seed-to-sale solution.

Kasteler is the CEO of Insure-Rite, Inc. Based in Salt Lake City, Utah, Insure-Rite provides information technology services to state insurance regulators in determining motorists’ insurance coverage, and provides real-time insurance coverage data to law enforcement officers during traffic stops. The company’s complex yet efficient real-time data management has drastically reduced the incidence of uninsured drivers in the markets where the company operates.

Jeremy Roberts, Medical Cannabis Payment Solutions CEO, said of Kasteler’s appointment, “Richard’s experience in working with regulators to manage large, real-time databases is exactly the kind of expertise that will help our company expand its services to governmental agencies charged with overseeing the medical cannabis marketplace. We’re very happy to have someone with his insights on our team.”

“Our philosophy at Insure-Rite is that responsibility is the cornerstone of personal freedom. I see that same value reflected in the management and company outlook of Medical Cannabis Payment Systems,” said Richard Kasteler, newly appointed board member. “I’m confident that my background of working with government regulators and policymakers to ensure compliance with legal requirements can help Medical Cannabis Payment Systems fulfill its mission in this area, and I’m glad to have been offered this opportunity.”

About Medical Cannabis Payment Systems, Inc.

Our mission is to provide end-to-end management, across multiple management systems, for medicinal marijuana operations. Many medicinal marijuana companies have experienced such rapid growth that they are finding it difficult to manage all aspects of their operation. In order to become a successful and compliant medicinal marijuana operation, effective management must depend on many different systems. REFG solves the fragmentation problem by identifying tools that are important to dispensaries, and customizing those tools specifically catered to the industry. We strive to create awareness within the medicinal marijuana industry and to develop an environmentally friendly, economically sustainable business while increasing shareholder value. For more information, please visit the company's website at:


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of REFG, Inc. to be materially different from the statements made herein.



Medical Cannabis Payment Systems, Inc.

Jeremy Roberts


To view this press release as a PDF file, click onto the following link:

Source: Medical Cannabis Payment Solutions (OTC Pink:REFG)

Maximum News Dissemination by FSCwire.

Copyright © 2014 Filing Services Canada Inc.

Press Information

Published by
Fred Gautreau

# 566 Words
Related Articles
More From Business
Sampo plc: Disclosure Under Chapter 9 Section [..]
SAMPO PLC      STOCK EXCHANGE RELEASE       23 March 2017 at 2:00 pm Disclosure Under Chapter 9 Section 5 of the [..]
Herantis Pharmas clinical study with CDNF in [..]
Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Sweden Herantis Pharma PlcCompany release [..]
H.B. Fuller Announces Conference Call and Webcast [..]
ST. PAUL, Minnesota - H.B. Fuller Company (NYSE: FUL) announced today that it will issue its first quarter 2017 earnings [..]
Agfa-Gevaert : Publication of a transparency notification [..]
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium - March 22, [..]
Klövern AB: Klövern's Annual report and Sustainability [..]
Klövern's Annual report (Swedish version) and Sustainability report (Swedish version) for 2016 are now available for downloading [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.